


Stem-Ross Weight Loss Center has served Baltimore, MD since 1994, providing medically supervised weight loss programs under the direction of Dr. Emil Kfoury. With three decades of experience in metabolic medicine, the clinic combines pharmaceutical interventions with body contouring services to address both weight reduction and aesthetic concerns. The center's longevity in Baltimore reflects a sustained approach to obesity medicine that has adapted to include newer pharmacological options while maintaining individualized patient care protocols.
The clinic currently offers semaglutide therapy as part of its pharmaceutical weight loss arsenal. Semaglutide, a GLP-1 receptor agonist, works by regulating appetite signals and slowing gastric emptying to reduce caloric intake. Dr. Kfoury prescribes semaglutide following comprehensive metabolic assessments that include body composition analysis, medical history review, and evaluation of contraindications. Dosing protocols are adjusted based on individual tolerance and weight loss response, with patients typically starting at lower doses and titrating upward over several weeks. The center also provides nutritional supplementation programs designed to support metabolic function during caloric restriction and prevent common deficiencies associated with rapid weight loss.
Dr. Emil Kfoury brings extensive experience in bariatric medicine to his practice at Stem-Ross Weight Loss Center. His approach emphasizes medical oversight throughout the weight loss process, with regular monitoring of vital signs, metabolic markers, and body composition changes. Patients receive ongoing assessments to track progress and adjust treatment protocols as needed. The clinic's body contouring services address the aesthetic concerns that often accompany significant weight loss, including skin laxity and localized fat deposits resistant to diet and exercise. This dual focus allows patients to pursue both metabolic health improvements and cosmetic refinement within a single medical practice.
Patients at Stem-Ross Weight Loss Center attend in-person consultations at the Baltimore location, where they undergo initial evaluations and receive ongoing care. The intake process includes detailed medical history documentation, current medication review, and discussion of weight loss goals and timelines. Follow-up appointments are scheduled based on the treatment protocol, with semaglutide patients typically seen every four to six weeks during the titration phase. The clinic provides specific dietary guidance tailored to GLP-1 therapy, addressing common side effects such as nausea and helping patients optimize protein intake during weight reduction. Supplement protocols are customized based on individual nutritional assessments and deficiency risk factors.
With a 4.9-star rating from 19 Google reviews, Stem-Ross Weight Loss Center has established a reputation for consistent patient outcomes in the Baltimore area. The clinic's three-decade presence in the community provides institutional knowledge about long-term weight management challenges and the evolving landscape of obesity pharmacotherapy. Dr. Kfoury's practice model focuses on patients who require medical intervention for weight loss, particularly those with BMI classifications that warrant pharmaceutical support or who have struggled with traditional diet and exercise approaches. The combination of established medical weight loss expertise and incorporation of contemporary peptide therapies like semaglutide positions the center as a resource for Baltimore residents seeking physician-supervised metabolic treatment.
Dr. Emil Kfoury
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


